PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Cancer Biomarker and Biotherapeutics, Barts Cancer Institute, London, UK d.ullah@qmul.ac.uk.\', \'Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.\', \'Centre for Cancer Biomarker and Biotherapeutics, Barts Cancer Institute, London, UK.\', \'Centre for Tumour Biology, Barts Cancer Institute, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2020-045077
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33875444
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all